AXGN
Axogen Inc
43.40$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 44.9% | 44.7% | 42.2% | 43.5% | 44.9% | 48.7% | 47.4% | 50.3% | 52.9% | 54.3% | 63.8% | 65.7% | |
| 19.1% | 15.8% | 8.4% | 10.2% | 9.7% | 13.5% | 9.2% | 12.7% | 11.0% | 16.0% | 28.6% | 31.0% | |
| 19.8% | 15.8% | 9.5% | 11.2% | 12.8% | 16.4% | 11.3% | 17.5% | 16.5% | 16.0% | 28.6% | 31.0% | |
| 12.0% | 12.8% | 13.0% | 13.3% | 12.8% | 11.8% | 13.4% | 13.6% | 14.2% | 11.8% | 9.8% | 11.2% | |
| 11.8% | 11.7% | 14.8% | 14.8% | 15.3% | 16.3% | 18.1% | 17.9% | 18.8% | 19.1% | 15.9% | 15.5% | |
| 52.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 2.2% | 2.3% | 2.6% | 2.6% | 2.7% | 2.7% | 3.0% | 3.0% | 3.0% | 3.0% | 2.5% | 2.5% | |
| 49.7% | 51.4% | 50.1% | 49.4% | 48.2% | 49.0% | 46.3% | 45.4% | 44.2% | 41.9% | 15.4% | 15.9% | |
| 13.7% | 15.5% | 12.3% | 12.4% | 12.0% | 15.0% | 11.1% | 12.2% | 12.9% | 10.6% | 9.0% | 10.0% | |
| 0.6% | 0.8% | 0.9% | 0.9% | 1.0% | 1.0% | 1.1% | 1.1% | 1.1% | 1.1% | 0.7% | 0.6% | |
| 13.1% | 6.0% | 11.4% | 11.5% | 11.0% | 3.9% | 10.0% | 11.1% | 11.9% | 1.3% | 8.3% | 9.3% | |
| 23.8% | 23.7% | 25.1% | 24.9% | 24.6% | 23.3% | 24.3% | 23.3% | 22.3% | 21.8% | – | – | |
| 50.3% | 48.6% | 49.9% | 50.6% | 51.8% | 51.0% | 53.7% | 54.6% | 55.8% | 58.1% | 84.6% | 84.1% | |
| -142.5% | -142.9% | -154.4% | -153.4% | -151.9% | -143.0% | -150.4% | -143.3% | -135.8% | -138.5% | -112.8% | -107.6% | |
| 22.1% | 21.9% | 23.2% | 23.1% | 22.9% | 23.6% | 23.0% | 22.2% | 21.2% | 21.2% | 17.8% | 17.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.